Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 401-540-3 | CAS number: 84632-65-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1987
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- May 12, 1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.7 (Repeated Dose (28 Days) Toxicity (Oral))
- Version / remarks:
- September 19, 1984
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 401-540-3
- EC Name:
- -
- Cas Number:
- 84632-65-5
- Molecular formula:
- C18H10Cl2N2O2
- IUPAC Name:
- 3,6-bis(4-chlorophenyl)-1H,2H,4H,5H-pyrrolo[3,4-c]pyrrole-1,4-dione
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: KFM Kleintierfarm Madoerin AG, Fuellinsdorf/Switzerland
- Age at study initiation: 7-9 meeks
- Weight at study initiation: males: 147 - 173 g, females: 157 - 181 g
- Fasting period before study:
- Housing: Individually
- Diet (e.g. ad libitum): Pelleted standard Kliba no. 343 Batch 44/86 rat maintenance diet ('Kliba', Klingentalmuehle AG, Kaiseraugst, Switzerland), at
libitum.
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40-70
- Air changes (per hr): 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 h / 12 h
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test article was weighed into a glass beaker on a tared Mettler PK 300 balance and the vehicle, polyethylene glycole (PEG 400), was added. The mixture was prepared daily prior to administration using a homogenizer and kept stable during application with a magnetic stirrer.
Concentrations, homogeneity, and stability were checked by RCC analytical laboratories for all preparations.
VEHICLE
- Amount of vehicle (if gavage): 10 ml/kg body weight - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- Once daily, 7 days per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
Based upon the results in acute toxicity studies, which did not indicate any toxicity at limit test doses.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Observations for mortality were recorded twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Signs of toxicity were assessed twice daily. A description of any abnormalities were recorded and the subsequent progress was monitored.
BODY WEIGHT: Yes
- Time schedule for examinations: The body weight of each animal was recorded weekly during the acclimation and treatment period using an on-line
electronic recording system.
FOOD CONSUMPTION: Yes
- The food consumption was recorded once during the acclimation period and weekly thereafter using an online electronic recording system.
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: Examinations were performed at termination of treatment.
Ten minutes after the application of a mydriatic solution (Dispersa AG, Winterthur / Switzerland) the cornea, lens, anterior chamber, vitreous body and ocular fundus of both eyes were examined under dimed light using a Heine Miroflex 2 Ophthalmoscope (Eisenhut Vet. AG, Allschwil / Switzerland)
- Dose groups that were examined: Ophthalmoscopic examinations were performed on all animals.
HAEMATOLOGY: Yes, from the retro-orbital plexus
- Time schedule for collection of blood: after 4 weeks
- Anaesthetic used for blood collection: Yes, under light ether anesthesia
- Animals fasted: Yes, the animals were fasted for 18 hours before blood sampling but water was provided.
- How many animals: all animals
- Parameters checked in table 1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: after 4 weeks
- Animals fasted: Yes, the animals were fasted for 18 hours before blood sampling but water was provided.
- How many animals: all animals
- Parameters checked in table 1 were examined.
URINALYSIS: Yes
- Time schedule for collection of urine: after 4 weeks, over an 18-hour period into a specimen
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- Parameters checked in table 1 were examined.
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, all animals were necropsied and descriptions of all macroscopic abnormalities were recorded. Necropsies were performed
by experienced prosectors supervised by a pathologist. All animals surviving to the end of the observation period and all moribund animals were anesthetized by intraperitoneal injection of sodium pentobarbitone and killed by exsanguination after 4 weeks.
Samples of the following tissues and organs were collected from all animals at necropsy and fixed in neutral phosphate buffered 4 % formaldehyde solution.
Adrenal glands, Heart, Kidneys, Liver, Spleen, Gross lesions.
Where there was a compound related alteration in an organ, this organ was histologically examined in all animals of all dose groups.
Organ weights: The following organ weights were taken from all animals necropsied at termination of treatment: Adrenal glands, Kidneys,
Liver, Testes.
HISTOPATHOLOGY: Yes
Slides of all tissues collected at terminal sacrifice from the animals of the control and high-dose groups as well as all animals which died spontaneously were examined by a pathologist. Treatment-related morphologic changes in the organs of any highdose animal required histological evaluation of the same organs in lower dose groups until a no-effect-level was determined. All abnormalities were described and included in the report.
HISTOTECHNOLOGY
All organ and tissue samples, as defined under Histopathology were processed, embedded and cut at a thickness of 2-4 micrometers and stained with hematoxylin and eosin. Special stains were used at the discretion of the pathologist. - Other examinations:
- No other examinations were performed.
- Statistics:
- The following statistical methods were used to analyze the body weights, food consumption and organ weights:
- Univariate one-way analysis of variance was used to assess the significance of intergroup differences.
- If the variables could be assumed to follow a normal distribution, the Dunnett-test (many to one t-test) based on a pooled variance estimate was applied for the comparison between the treated groups and the control groups.
- The Steel-test (many-one rank test) was applied when the data could not be assumed to follow a normal distribution.
- For the overall spontaneous mortality data, the Fisher's exact test for 2x2 tables was applied.
- Group means were calculated for continuous data and medians were calculated for discrete data (scores) in the summary tables.
- Individual values, means, standard deviations and statistics were rounded off before printing. For example, test statistics were calculated on the basis of exact values for means and pooled variances and then rounded off to two decimal places. Therefore, two groups may display the same printed means for a given parameter, yet display different test statistics values.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Starting with day 21 until termination of treatment all rats of the high dose group (1000 mg/kg bw) showed red discolored extremities. In addition red
discolored feces were observed in the same animals betmeen day 18 and termination of the test. No other symptoms related to test article treatment were observed.
Treatment-unrelated signs and symptoms:
Prior to death, one female animal of the group with 300 mg/kg showed moderate sedation (days 17-19), rales (days 18-19) and moderate ruffled fur (days 17-19). - Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- Due to a possible intubation error, two female animals, one of the control group and one of the group 300 mg/kg died spontaneously at day 17 respectively 20 of test.
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- The assessment of hematological data indicated no changes of toxicological significance at termination of the treatment.
Treatment-unrelated: All statistical differences in the results of the hematology parameters were considered to be incidental and of normal biological variation. - Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- The assessment of biochemical data indicated no changes of toxicological significance at termination of the treatment.
Treatment-unrelated: All statistical differences in the results of the clinical biochemistryparameters were considered to be incidental and of normal biological variation. - Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- The assessment of urinalysis data indicated no changes of toxicological significance at termination of the treatment.
Treatment-unrelated: All statistical differences in the results of the urinalysis parameters were considered to be incidental and of normal biological variation. - Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- not examined
- Details on results:
- HISTOPATHOLOGY:
- No treatment related microscopic findings were recorded. From the tissues examined no cause of death could be established for the two rats which died. The various spontaneous microscopic findings recorded are within the normal range observed in this age and strain of rat. They can be attributed to subclinical infections, spontaneous congenital abnormalities or physiological status.
The nephroblastoma which mas recorded in one male of the 300 mg/kg body weight group is a seldom encountered malignant kidney tumor which occurs spontaneously with a Iow incidence in many rat strains and is not related to treatment.
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity
- Key result
- Critical effects observed:
- no
- System:
- other: none
Applicant's summary and conclusion
- Conclusions:
- Based upon the results obtained in the study, the NOAEL for the 28-day repeated dose oral toxicity test of the substance was considered to be higher than 1000 mg/kg/day for male and female rats when administered orally by gavage.
- Executive summary:
In a study according to OECD Test Guideline 407 under GLP conditions, Wistar rats were treated with three doses of the substance (100, 300 and 1000 mg/kg bw). The dose were applied by oral (gavage) daily for four weeks. Besides some clinical findings caused by the colour of the substance, no treatment-related effects were observed. Therefore, the NOAEL was considered to be higher than 1000 mg/kg/day for male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.